10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-039701`
Period End Date	20200630
Filing Date	20200812
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	tyme-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 27 Cash Flow Statement 43 Stockholders Equity 17

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.70M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$585.52K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$396.96K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$733.32K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$981.95K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$22.63M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.18K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.89K	USD	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$80.80K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$150.30K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total assets	`Assets`	$29.50M	USD	Point-in-time
Total assets	`Assets`	$23.98M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts payable and other current liabilities (including $235,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$4.47M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	126.61M	shares	Point-in-time
Accounts payable and other current liabilities (including $235,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.83M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	123.31M	shares	Point-in-time
Severance payable	`SeverancePayableCurrent`	$380.72K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Severance payable	`SeverancePayableCurrent`	$386.46K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	126.61M	shares	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$467.78K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.80M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$347.45K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$518.12K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$54.66K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$40.05K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.71M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.58M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.16M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.25M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$3.64M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$1.28M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.48M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.15M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 126,610,446 issued and outstanding at June 30, 2020, 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$12.66K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 126,610,446 issued and outstanding at June 30, 2020, 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$12.33K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$126.83M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$132.46M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-116.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.82M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.03M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.99M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$29.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$23.98M	USD	Point-in-time

Income Statement 27 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$152.00K	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$203.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.72M	USD	1 Quarter
General and administrative (including $203,000 and $152,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.46M	USD	1 Quarter
General and administrative (including $203,000 and $152,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.06M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.18M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.77M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.18M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.77M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.94M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.26M	USD	1 Quarter
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$10.50K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$80.24K	USD	1 Quarter
Interest expense	`InterestExpense`	$32.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$29.38K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$2.99M	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-1.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	124.58M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.86M	shares	1 Quarter

Cash Flow Statement 43 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-8.83M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.19M	USD	1 Quarter
Depreciation	`Depreciation`	$1.30K	USD	1 Quarter
Depreciation	`Depreciation`	$1.29K	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$1.62M	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$1.07M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.94M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.26M	USD	1 Quarter
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	1 Quarter
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-144.83K	USD	1 Quarter
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$188.56K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-248.63K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-445.38K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-69.51K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-73.55K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-528.77K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.64M	USD	1 Quarter
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-91.90K	USD	1 Quarter
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-156.03K	USD	1 Quarter
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.07M	USD	1 Quarter
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.33M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-6.85K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-14.61K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.39M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.60M	USD	1 Quarter
Insurance note payments	`InsuranceNotePayments`	$402.00K	USD	1 Quarter
Insurance note payments	`InsuranceNotePayments`	$170.67K	USD	1 Quarter
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$1.17M	USD	1 Quarter
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$11.17M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.77M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.16M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-5.39M	USD	1 Quarter
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.47M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.31M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.47M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.31M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Interest	`InterestPaidNet`	$29.38K	USD	1 Quarter
Interest	`InterestPaidNet`	$32.98K	USD	1 Quarter

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	126.61M	shares	Point-in-time
Warrant to share exchange	`StockIssuedDuringPeriodValueWarrantToShareExchange`	$3.39M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.62M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	126.61M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.